Jonathan P Charles (Jonathan Charles)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Silver Nanoparticles

Machine Learning

Liver Metastases

Top Venues

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan P Charles, Nariman Nezami, Mohammad Loya, Samuel Shube, Cliff Davis, Glenn Hoots, Jamil Shaikh
Portal Vein Embolization: Rationale, Techniques, and Outcomes to Maximize Remnant Liver Hypertrophy with a Focus on Contemporary Strategies. Life (Basel, Switzerland) 13 (2) (2023)
Jonathan P Charles, Nariman Nezami, Mohammad Loya, Samuel Shube, Cliff Davis, Glenn Hoots, Jamil Shaikh
Portal Vein Embolization: Rationale, Techniques, and Outcomes to Maximize Remnant Liver Hypertrophy with a Focus on Contemporary Strategies. Life (Basel, Switzerland) 13 (2) (2023)
Jonathan P Charles, Nariman Nezami, Mohammad Loya, Samuel Shube, Cliff Davis, Glenn Hoots, Jamil Shaikh
Portal Vein Embolization: Rationale, Techniques, and Outcomes to Maximize Remnant Liver Hypertrophy with a Focus on Contemporary Strategies. Life (Basel, Switzerland) 13 (2) (2023)
Arian Mansur, Andrea Vrionis, Jonathan P Charles, Kayesha Hancel, John C Panagides, Farzad Moloudi, Shams Iqbal, Dania Daye
The Role of Artificial Intelligence in the Detection and Implementation of Biomarkers for Hepatocellular Carcinoma: Outlook and Opportunities. Cancers 15 (11) (2023)
Jonathan P Charles, Andrea Vrionis, Arian Mansur, Trevor J Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang, Nariman Nezami
Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. Cancers 15 (9) (2023)
Jonathan P Charles, Andrea Vrionis, Arian Mansur, Trevor J Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang, Nariman Nezami
Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. Cancers 15 (9) (2023)